ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281617 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281617; 2) Community: the network communities that were significantly associated with the response to NSC 281617; 3) Molecule: the relationships between components within communities and NSC 281617; 4) MDR: the compounds that were significantly associated with the NSC 281617.

NSC Compound Enrichment Correlation
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0414190425892871 0.10654582
NSC 631391 7H-Pyrido[4,3-c]carbazole-6-methanol,methylcarbamate (ester) (9CI) 0.0414190425892871 0.31693816
NSC 639174 Camptothecin Derivative 0.0414190425892871 0.5816179
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0414190425892871 0.48503298
NSC 661820 Null 0.0414190425892871 0.14125406
NSC 662123 Null 0.0414190425892871 0.090339887
NSC 673452 Null 0.0414190425892871 0.18930557
NSC 676395 Cyclobutanemethanol, 1-[[(2-amino-4-chloro-5-[(4-chlorophenyl)azo]- 6-pyrimidinyl)amino]methyl]-3-(3-phenylmethoxy)- 0.0414190425892871 0.21811693
NSC 676774 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-6-deoxy-.beta.-D-gulopyranosyl]- .b 0.0414190425892871 -0.25411881
NSC 676944 Null 0.0414190425892871 0.18876418
Total:50  Current:38    [First] [Prev] [Next] [Last]